DrugDashboards
← Home
Manufacturing facility

Bausch Health Companies Inc.

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
Canada
Registered address
2150 boul Saint-Elzear O, Laval, Quebec H7L 4A8, Canada (CAN)
Operations here
analysislabelmanufacturepack
FDA identifiers
FEI 3002807186 · DUNS 245141858

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • NAIDrug Quality Assurance2024-01-19
  • NAIDrug Quality Assurance2022-09-29
  • NAIDrug Quality Assurance2019-09-19
  • NAIDrug Quality Assurance2017-02-17
  • VAIDrug Quality Assurance2015-02-20
  • VAIDrug Quality Assurance2014-06-17
  • VAIDrug Quality Assurance2013-09-20
  • VAIDrug Quality Assurance2011-07-28
  • VAIDrug Quality Assurance2008-10-30

Drugs this plant is listed as making

36 distinct drugs across 85 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.